Aveanna Healthcare Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview

Aveanna Healthcare Holdings

06/11/2024 14:17

* Aveanna Healthcare Holdings Inc  AVAH.OQ   AVAH.O  is
expected
to show a rise in quarterly revenue when it reports  results on
November 7 for the period ending September 30 2024
    * The Atlanta Georgia-based  company is expected to report a
3.8% increase in revenue to $496.02 million from $478.01 million
a year ago, according to the mean estimate from 7 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Aveanna Healthcare
Holdings
Inc is for a loss of 1 cent per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 5
"hold" and 2 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aveanna
Healthcare Holdings Inc is 5.00​, above​ its last closing price
of $4.63. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.01       -0.02      0.01      Beat    150
 Mar. 31 2024  -0.05       -0.05      -0.03     Beat    36.8
 Dec. 31 2023  -0.02       -0.02      -0.02     Met     15.8​
 Sep. 30 2023  -0.03       -0.03      -0.03     Met     -12.5
 ​​Jun.        -0.04       -0.04      -0.02     Beat    44.8
 30 2023                                                
 Mar. 31 2023  -0.06       -0.06      -0.05     Beat    18.6​
 Jan. 1 0001   -0.01       -0.02      -0.03     Missed  -81
 Sep. 30 2022  0.03        0.04       -0.03     Missed  -185.7
 This summary was machine generated November 6 at 14:17 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)